Thursday, April 03, 2014 7:47:14 PM
What catches my attention with the RR patient is stated in Fig 3 on pg 5...
"Fig 3. Enhancing lesion volumes and numbers on serial magnetic resonance images were significantly decreased with treatment as compared with pretreatment baseline, increased back to baseline after treatment, and then were again significantly decreased with reinstitution of treatment in relapsing remitting (RR), but not secondary progressive (SP), patients....."
"Fig 3. Enhancing lesion volumes and numbers on serial magnetic resonance images were significantly decreased with treatment as compared with pretreatment baseline, increased back to baseline after treatment, and then were again significantly decreased with reinstitution of treatment in relapsing remitting (RR), but not secondary progressive (SP), patients....."
Recent TOVX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 08:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:10:12 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/16/2026 09:32:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 12:15:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:10:35 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2026 09:35:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 01:07:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 02:11:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:55:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:54:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:53:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:51:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/06/2026 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2025 01:00:58 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/23/2025 10:04:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 10:21:47 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/03/2025 09:00:29 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/03/2025 05:15:04 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/12/2025 09:11:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 01:16:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 01:10:35 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/10/2025 09:33:38 PM
